Home > Mind control: Top neurotech firms can hoard and share patients' brain data

News
Mind control: Top neurotech firms can hoard and share patients' brain data

Description

The world's top neurotechnology companies can keep indefinite possession of the data generated by the brains of their trial subjects and customers, and even share it with third parties, according to upcoming research. FRANCE 24's Tech Ed…

Added on the 14/07/2023 16:02:04 - Copyright : France 24 EN

To customise your video :

More videos on the subject

WHO chief slams wealthy countries for failing to share virus data

The head of the World Health Organization accuses some wealthy countries of being "well behind" in sharing data…

04/02/2020 - AFPTV - First imag…
Darmanin in Frontignan to salute firefighters as pine…

19/08/2024 - AFPTV…
Muslim top diplomats meet in Jeddah amid fears…

07/08/2024 - AFPTV…
Traffic and pedestrians on Dhaka street after military takes control of Banglad…

Traffic and pedestrians on a busy street in Dhaka, Bangladesh a day after the military took control as mass…

06/08/2024 - AFPTV - First imag…
UK's Starmer warns social media firms to uphold law over mi…

01/08/2024 - AFPTV…
Fire 'under control' at France's Rouen cathedral

11/07/2024 - AFPTV…

News
Mind control: Top neurotech firms can hoard and share patients' brain data

More videos on the subject

WHO chief slams wealthy countries for failing to share virus data

Darmanin in Frontignan to salute firefighters as pine…

Muslim top diplomats meet in Jeddah amid fears…

Traffic and pedestrians on Dhaka street after military takes control of Banglad…

UK's Starmer warns social media firms to uphold law over mi…

Fire 'under control' at France's Rouen cathedral

More videosNews

Ukraine: après la reprise de la ville, Zelensky...

DemainEntreprendre - épisode 12

Ouverture d'un nouveau secteur: combien de temps...

News Mind control: Top neurotech firms can hoard and share patients' brain data

More videos on the subject

More videosNews

News
Mind control: Top neurotech firms can hoard and share patients' brain data